Page last updated: 2024-08-23

etoposide and Proliferative Vitreoretinopathy

etoposide has been researched along with Proliferative Vitreoretinopathy in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jurgensen, S; Nair, AR; Ramabhadran, R; Schliekelman, M; Thomas, MB; Wakefield, J	1
Chen, YH; Hu, DN; Kuo, HK; Wu, PC; Wu, YC; Yang, PM	1

Other Studies

2 other study(ies) available for etoposide and Proliferative Vitreoretinopathy

Article	Year
Inhibition of p53 by lentiviral mediated shRNA abrogates G1 arrest and apoptosis in retinal pigmented epithelial cell line. Cell cycle (Georgetown, Tex.), 2005, Volume: 4, Issue:5 Topics: Apoptosis; Camptothecin; Cell Cycle; Cell Line; Cell Proliferation; DNA Damage; Etoposide; G1 Phase; Gene Expression Regulation; Genes, p53; Genetic Vectors; Humans; Lentivirus; Pigment Epithelium of Eye; Promoter Regions, Genetic; RNA Interference; RNA, Messenger; Tumor Suppressor Protein p53; Vitreoretinopathy, Proliferative	2005
Effects of topoisomerase II inhibitors on retinal pigment epithelium and experimental proliferative vitreoretinopathy. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2007, Volume: 23, Issue:1 Topics: Animals; Cell Survival; Cells, Cultured; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Etoposide; In Vitro Techniques; Injections; Male; Maximum Tolerated Dose; Pigment Epithelium of Eye; Rabbits; Topoisomerase II Inhibitors; Vitreoretinopathy, Proliferative; Vitreous Body	2007

Article

Year

Inhibition of p53 by lentiviral mediated shRNA abrogates G1 arrest and apoptosis in retinal pigmented epithelial cell line.

Cell cycle (Georgetown, Tex.), 2005, Volume: 4, Issue:5

Topics: Apoptosis; Camptothecin; Cell Cycle; Cell Line; Cell Proliferation; DNA Damage; Etoposide; G1 Phase; Gene Expression Regulation; Genes, p53; Genetic Vectors; Humans; Lentivirus; Pigment Epithelium of Eye; Promoter Regions, Genetic; RNA Interference; RNA, Messenger; Tumor Suppressor Protein p53; Vitreoretinopathy, Proliferative

2005

Effects of topoisomerase II inhibitors on retinal pigment epithelium and experimental proliferative vitreoretinopathy.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2007, Volume: 23, Issue:1

Topics: Animals; Cell Survival; Cells, Cultured; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Etoposide; In Vitro Techniques; Injections; Male; Maximum Tolerated Dose; Pigment Epithelium of Eye; Rabbits; Topoisomerase II Inhibitors; Vitreoretinopathy, Proliferative; Vitreous Body

2007